×
About 3,937 results

ALLMedicine™ Gallbladder Cancer Center

Research & Reviews  1,919 results

Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treat...
https://doi.org/10.1001/jamaoncol.2020.6166
JAMA Oncology; Ramaswamy A, Ostwal V et. al.

Dec 3rd, 2020 - There is therapeutic uncertainty regarding use of combination or single-agent chemotherapy in the treatment of patients with gallbladder cancer who experience disease progression after first-line chemotherapy. To compare the efficacy of capecitabi...

Clinical practice guidelines for the management of biliary tract cancers 2019: the 3rd ...
https://doi.org/10.1002/jhbp.870
Journal of Hepato-biliary-pancreatic Sciences; Nagino M, Hirano S et. al.

Dec 1st, 2020 - The Japanese Society of Hepato-Biliary-Pancreatic Surgery launched the clinical practice guidelines for the management of biliary tract cancers (cholangiocarcinoma, gallbladder cancer, and ampullary cancer) in 2007, then published the 2nd version ...

Tumor-suppressive microRNA-551b-3p targets H6PD to inhibit gallbladder cancer progression.
https://doi.org/10.1038/s41417-020-00252-x
Cancer Gene Therapy; Ji T, Gao L et. al.

Nov 30th, 2020 - Gallbladder cancer (GBC) is a highly malignant cancer with poor prognosis. Extensive studies have reported the vital functionality of several microRNAs (miRNAs) in numerous human cancers, including GBC. Microarray analysis has identified the diffe...

Anton's syndrome as a presentation of Trousseau syndrome involving the bilateral optic ...
https://doi.org/10.1177/0300060520972907
The Journal of International Medical Research; Cao S, Zhu X et. al.

Nov 25th, 2020 - Anton's syndrome is a rare neuropsychiatric syndrome that is characterized by cortical blindness and anosognosia with visual confabulation, but without global cognitive impairment. We herein report a rare case of Anton's syndrome as a presentation...

PTEN deficiency facilitates the therapeutic vulnerability to proteasome inhibitor borte...
https://doi.org/10.1016/j.canlet.2020.11.016
Cancer Letters; Jiang TY, Feng XF et. al.

Nov 21st, 2020 - Gallbladder cancer (GBC) is an aggressive malignancy of biliary tract with poor prognosis. Although several studies have shown the frequency of relevant genetic alterations, there are few genetic models or translational studies that really benefit...

see more →

Guidelines  5 results

Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline
http://ascopubs.org/doi/full/10.1200/JCO.18.02178

Mar 10th, 2019 - PURPOSE To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with resected biliary tract cancer. METHODS ASCO convened an Expert Panel to conduct a systematic review of the literature on adju...

Rising cancer incidence in younger adults: is obesity to blame?
https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(19)30017-9/fulltext
Marinac,C.,et al

Feb 2nd, 2019 - Although cancer has historically been considered a disease of aging, a reported sharp rise in colorectal cancer incidence among adults aged 54 years and younger beginning in the mid-1980s for the colon and mid-1970s for the rectum has motivated re...

Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry
https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(18)30267-6/fulltext
Sung,H.,et al

Feb 2nd, 2019 - Cancer trends in younger adults, often under 50 years, reflect recent changes in carcinogenic exposures, which could foreshadow the future overall disease burden. Previous studies reported an increase in early onset colorectal cancer, which could ...

Gallbladder cancer: expert consensus statement.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527853
HPB : the Official Journal of the International Hepato Pancreato Biliary Association; Aloia TA, Járufe N et. al.

Jul 14th, 2015 - An American Hepato-Pancreato-Biliary Association (AHPBA)-sponsored consensus meeting of expert panellists was convened on 15 January 2014 to review current evidence on the management of gallbladder carcinoma in order to establish practice guidelin...

Modification and implementation of NCCN guidelines on hepatobiliary cancers in the Midd...
https://doi.org/10.6004/jnccn.2010.0123
Journal of the National Comprehensive Cancer Network : JNCCN; Yusuf MA, Kapoor VK et. al.

May 10th, 2011 - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) on Hepatobiliary Cancers address hepatocellular cancer, cancer of the gallbladder, extrahepatic cholangiocarcinoma, and intrahepatic cholangiocarcinoma. Hepatocellular cancer inci...

see more →

Clinicaltrials.gov  1,969 results

Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treat...
https://doi.org/10.1001/jamaoncol.2020.6166
JAMA Oncology; Ramaswamy A, Ostwal V et. al.

Dec 3rd, 2020 - There is therapeutic uncertainty regarding use of combination or single-agent chemotherapy in the treatment of patients with gallbladder cancer who experience disease progression after first-line chemotherapy. To compare the efficacy of capecitabi...

Clinical practice guidelines for the management of biliary tract cancers 2019: the 3rd ...
https://doi.org/10.1002/jhbp.870
Journal of Hepato-biliary-pancreatic Sciences; Nagino M, Hirano S et. al.

Dec 1st, 2020 - The Japanese Society of Hepato-Biliary-Pancreatic Surgery launched the clinical practice guidelines for the management of biliary tract cancers (cholangiocarcinoma, gallbladder cancer, and ampullary cancer) in 2007, then published the 2nd version ...

Gallbladder cancer - Care at Mayo Clinic - Mayo Clinic
https://www.mayoclinic.org/diseases-conditions/gallbladder-cancer/care-at-mayo-clinic/mac-20353377

Dec 1st, 2020 - Gallbladder cancer care at Mayo Clinic Mayo Clinic specialists provide expert, personalized care for people with gallbladder cancer. Your Mayo Clinic care team At Mayo Clinic, oncologists, gastroenterologists, radiation oncologists, pathologists a...

Gallbladder cancer - Symptoms and causes - Mayo Clinic
https://www.mayoclinic.org/diseases-conditions/gallbladder-cancer/symptoms-causes/syc-20353370

Dec 1st, 2020 - We're welcoming patients at Mayo Clinic See our safety precautions in response to COVID-19. Request an appointment. Overview Gallbladder cancer Open pop-up dialog box Close Gallbladder cancer Gallbladder cancer Gallbladder cancer begins in the cel...

Gallbladder cancer - Diagnosis and treatment - Mayo Clinic
https://www.mayoclinic.org/diseases-conditions/gallbladder-cancer/diagnosis-treatment/drc-20353374

Dec 1st, 2020 - Diagnosis ERCP Open pop-up dialog box Close ERCP ERCP Endoscopic retrograde cholangiopancreatography (ERCP) uses a dye to highlight the bile ducts on X-ray images. A thin, flexible tube (endoscope) with a camera on the end is passed down your thro...

see more →

News  29 results

Surveillance for hepatobiliary cancers in primary sclerosing cholangitis
https://www.mdedge.com/internalmedicine/article/209796/hepatology/surveillance-hepatobiliary-cancers-primary-sclerosing?channel=75
Bianca Nogrady

Oct 9th, 2019 - All adult patients with primary sclerosing cholangitis should be screened at least annually for cholangiocarcinoma and gallbladder cancer, particularly in the first year after their diagnosis, according to a clinical update published in Clinical G.

AGA CPU: Surveillance for hepatobiliary cancers in primary sclerosing cholangitis
https://www.mdedge.com/gihepnews/article/209796/hepatology/aga-cpu-surveillance-hepatobiliary-cancers-primary-sclerosing?channel=346
Bianca Nogrady, MDedge News

Oct 9th, 2019 - All adult patients with primary sclerosing cholangitis should be screened at least annually for cholangiocarcinoma and gallbladder cancer, particularly in the first year after their diagnosis, according to a clinical update published in Clinical G.

AGA Clinical Practice Update: Surveillance for hepatobiliary cancers in primary sclerosing cholangitis
https://www.mdedge.com/gihepnews/article/209796/hepatology/aga-clinical-practice-update-surveillance-hepatobiliary-cancers?channel=346
Bianca Nogrady, MDedge News

Oct 9th, 2019 - All adult patients with primary sclerosing cholangitis should be screened at least annually for cholangiocarcinoma and gallbladder cancer, particularly in the first year after their diagnosis, according to a clinical practice update published in C.

Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline
http://ascopubs.org/doi/full/10.1200/JCO.18.02178

Mar 10th, 2019 - PURPOSE To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with resected biliary tract cancer. METHODS ASCO convened an Expert Panel to conduct a systematic review of the literature on adju...

Rising cancer incidence in younger adults: is obesity to blame?
https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(19)30017-9/fulltext
Marinac,C.,et al

Feb 2nd, 2019 - Although cancer has historically been considered a disease of aging, a reported sharp rise in colorectal cancer incidence among adults aged 54 years and younger beginning in the mid-1980s for the colon and mid-1970s for the rectum has motivated re...

see more →

Patient Education  15 results see all →